Recent Articles

  • College With Type 1 Diabetes During Coronavirus

    August 10, 2020

    Back to school season during the coronavirus pandemic has been met with several challenges, but for college students, preparation is still key, whether on-campus or at home.

  • Just Announced: More Affordable Insulin Options for Medicare Beneficiaries Coming Soon

    May 26, 2020

    JDRF welcomes the May 26th announcement by the Centers for Medicare & Medicaid Services about more affordable insulin options for people in the Medicare program.

  • Insulin Affordability Matters: Advocating to Make Insulin More Affordable for All

    November 14, 2019

    More than 1.25 million Americans live with type 1 diabetes (T1D), and this number continues to grow. They need insulin several times...

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

  • Fashion Brand Veronica Beard Gives Back to JDRF

    September 18, 2020

    Four fearless female leaders for JDRF who emulate the Veronica Beard brand share how JDRF has made a difference for the T1D community

  • The Power of the Patient Voice: JDRF Video

    September 10, 2020

    In the words of Colin Dayan, M.D., Ph.D., professor of clinical diabetes and metabolism at Cardiff University: “Type 1 diabetes is almost the only major autoimmune disease now that does not have a licensed immunotherapy.” And he’s going to change that.